Kleiton Silva Borges
-
- Cancer, Hypoxia, and Metabolism 8
-
- Glioma Diagnosis and Treatment 8
-
- Microtubule and mitosis dynamics 6
-
- Epigenetics and DNA Methylation 7
-
- Adrenal and Paraganglionic Tumors 6
-
- Cancer-related Molecular Pathways 5
-
- Acute Lymphoblastic Leukemia research 4
-
- Acute Myeloid Leukemia Research 3
- Co-authors
- Luíz Gonzaga ToneCarlos Alberto ScrideliAugusto Faria AndradeVanessa S. SilveiraMaría Sol BrassescoDaniel Antunes MorenoAdemilson Espencer Egea SoaresHarley Francisco de Oliveira
- Cited by
- Cancer ResearchGeneticsCell Biology
- Journals
- Anti-Cancer Drugs (3 papers)Investigational New Drugs (2 papers)Molecular and Cellular Endocrinology (2 papers)
- Partner nations
- BrazilUnited StatesJapan
In The Last Decade
Kleiton Silva Borges
30 papers receiving 488 citations
Peers
Comparison fields: 5 of 70
- Cancer Research 112
- Genetics 78
- Cell Biology 76
- Molecular Biology 270
- Insect Science 37
Countries citing papers authored by Kleiton Silva Borges
This map shows the geographic impact of Kleiton Silva Borges's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kleiton Silva Borges with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kleiton Silva Borges more than expected).
Fields of papers citing papers by Kleiton Silva Borges
This network shows the impact of papers produced by Kleiton Silva Borges. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kleiton Silva Borges. The network helps show where Kleiton Silva Borges may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kleiton Silva Borges, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2022 | 6 | |
| 4 | 2021 | 12 | |
| 5 | 2020 | 30 | |
| 6 | 2020 | 2 | |
| 7 | 2020 | 40 | |
| 8 | 2020 | 2 | |
| 9 | 2019 | 2 | |
| 10 | 2019 | 13 | |
| 11 | 2018 | 9 | |
| 12 | 2017 | 17 | |
| 13 | 2016 | 17 | |
| 14 | 2015 | 26 | |
| 15 | 2013 | 27 | |
| 16 | 2013 | 8 | |
| 17 | 2012 | 20 | |
| 18 | 2012 | 15 | |
| 19 | 2011 | 43 | |
| 20 | Down Syndrome: advances and perspectives | 2007 | 0 |
About Kleiton Silva Borges
Kleiton Silva Borges is a scholar working on Genetics, Cancer Research and Cell Biology, having authored 32 papers that have together received 495 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (8 papers), Glioma Diagnosis and Treatment (8 papers), Epigenetics and DNA Methylation (7 papers), Microtubule and mitosis dynamics (6 papers), Adrenal and Paraganglionic Tumors (6 papers), Cancer-related Molecular Pathways (5 papers), Acute Lymphoblastic Leukemia research (4 papers) and Acute Myeloid Leukemia Research (3 papers). The work is most often cited by research in Cancer Research (112 citations), Genetics (78 citations) and Cell Biology (76 citations). Kleiton Silva Borges has collaborated with scholars based in Brazil, United States and Japan. Frequent co-authors include Luíz Gonzaga Tone, Carlos Alberto Scrideli, Augusto Faria Andrade, Vanessa S. Silveira, María Sol Brassesco, Daniel Antunes Moreno, Ademilson Espencer Egea Soares, Harley Francisco de Oliveira, Rosane Gomes de Paula Queiróz and Carlos Gilberto Carlotti. Their work appears in journals such as Anti-Cancer Drugs, Investigational New Drugs, Molecular and Cellular Endocrinology, Scientific Reports and Cell Division.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.